MWA Stock Recent News

Here is how Mueller Water Products (MWA) and Proto Labs (PRLB) have performed compared to their sector so far this year.

NEW YORK , Feb. 10, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a leader in microwave ablation (MWA) technology, remains committed to advancing physician education and recently supported Dr. Hosai Todd-Hesham's participation in a specialized MWA training program at the Columbia Thyroid Center in New York City.

Mueller Water Products, Inc. (NYSE:MWA ) Q1 2025 Earnings Call Transcript February 5, 2025 9:30 AM ET Company Participants Whit Kincaid - Investor Relations Martie Zakas - Chief Executive Officer Steve Heinrichs - Chief Financial Officer and Chief Legal and Compliance Officer Paul McAndrew - President and Chief Operating Officer Conference Call Participants Joe Giordano - TD Cowen Brian Lee - Goldman Sachs Bryan Blair - Oppenheimer Deane Dray - RBC Capital Markets Mike Halloran - Robert W. Baird Walt Liptak - Seaport Research Operator Welcome, and thank you for standing by.

Mueller Water Products (MWA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Although the revenue and EPS for Mueller Water Products (MWA) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Mueller Water Products (MWA) came out with quarterly earnings of $0.25 per share, beating the Zacks Consensus Estimate of $0.19 per share. This compares to earnings of $0.13 per share a year ago.

Increased Net Sales 18.7 percent to $304.3 Million Reported Net Income per Diluted Share of $0.22 Achieved Adjusted Net Income per Diluted Share of $0.25 Raises Annual Guidance for Fiscal 2025 Net Sales and Adjusted EBITDA ATLANTA, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Mueller Water Products, Inc. (NYSE: MWA), a leading manufacturer and marketer of products and solutions used in the transmission, distribution and measurement of water in North America, announced financial results for its fiscal 2025 first quarter ended December 31, 2024. In the first quarter of 2025, the Company: Increased net sales 18.7 percent to $304.3 million as compared with $256.4 million in the prior year quarter Reported operating income of $47.4 million as compared with $22.8 million in the prior year quarter and increased adjusted operating income 78.2 percent to $52.4 million as compared with $29.4 million in the prior year quarter Reported operating margin of 15.6 percent as compared with 8.9 percent in the pri

NEW YORK , Feb. 3, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a leader in microwave ablation (MWA) technology, made a significant impact at the 2025 North American Society for Interventional Thyroidology (NASIT) conference.

NEW YORK , Jan. 27, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a leader in minimally invasive Microwave Ablation (MWA) technology, reflects on a landmark year of innovation and achievement.

ATLANTA, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Mueller Water Products, Inc. (NYSE: MWA) plans to release financial results for its first quarter ended December 31, 2024, after U.S. markets close on Tuesday, February 4, 2025. On Wednesday, February 5, 2025, at 9:30 a.m. ET, the Company will hold a conference call to discuss earnings and business results. Interested parties are invited to listen via webcast available on the Investor Relations section of the Company's website www.muellerwaterproducts.com. An archive of the webcast will be available for approximately 90 days following the call.